Intravenous Infusions Balance Sheet Health
Financial Health criteria checks 4/6
Intravenous Infusions has a total shareholder equity of GHS20.6M and total debt of GHS13.2M, which brings its debt-to-equity ratio to 64.3%. Its total assets and total liabilities are GHS46.8M and GHS26.3M respectively. Intravenous Infusions's EBIT is GHS6.5M making its interest coverage ratio 19.8. It has cash and short-term investments of GHS499.5K.
Key information
64.3%
Debt to equity ratio
GH₵13.23m
Debt
Interest coverage ratio | 19.8x |
Cash | GH₵499.52k |
Equity | GH₵20.57m |
Total liabilities | GH₵26.28m |
Total assets | GH₵46.85m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: IIL's short term assets (GHS23.0M) exceed its short term liabilities (GHS14.1M).
Long Term Liabilities: IIL's short term assets (GHS23.0M) exceed its long term liabilities (GHS12.2M).
Debt to Equity History and Analysis
Debt Level: IIL's net debt to equity ratio (61.9%) is considered high.
Reducing Debt: IIL's debt to equity ratio has increased from 27.7% to 64.3% over the past 5 years.
Debt Coverage: IIL's debt is well covered by operating cash flow (34.5%).
Interest Coverage: IIL's interest payments on its debt are well covered by EBIT (19.8x coverage).